Sprott Report, page-4

No doubt Speculator that the 40% of Bullzeye that is not owned by EMR must be an absolute thorn in the side of management trying to go places. How they will procure that remaining 40% is intriguing to me because it's my bet that it will be very high on the agenda for the EMR team. I just can't see them building a full blown operation at Bullzeye until they have 100% ownership.

Could another script offer be on the cards come July-August? I'm pretty sure there is a 12 month waiting period between the closure of one offer till the beginning of another. What would another script offer even look like? Sure, the EMR SP has increased dramatically over the 12 month period but it's not all attributed to the few holes they have drilled out there at Bullzeye. I reckon there is going to have to be some icing on the cake to get the Xinhe group across the line, but the vexed question is where does a standalone bullzeye valuation sit at today?